CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Abstract: We present Heterogeneous Parallel Virtual Machine (HPVM), a compiler framework for hardware-agnostic programming on heterogeneous compute platforms. HPVM introduces a hardware-agnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results